NHC director sells 5,937 shares at $200
National Healthcare Corp director HASSAN EMIL E reported an open-market sale of 5,937 shares of common stock at $200.00 per share on June 22, 2026, and now directly holds 65,595 shares.
Rhea-AI Filing Summary
National Healthcare Corp director HASSAN EMIL E reported an open-market sale of 5,937 shares of common stock at $200.00 per share on June 22, 2026, and now directly holds 65,595 shares.
The director also holds multiple stock option grants, each covering 7,500 underlying common shares, with exercise prices ranging from $55.75 to $171.42 and expiration dates from 2027 through 2031. These options represent ongoing equity-based compensation rather than new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Shares of Common Stock | 5,937 | $200.00 | $1.19M |
| holding | Option to Purchase Common Stock [2022 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2023 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2024 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2025 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2026 Grant] | -- | -- | -- |
Key Figures
Key Terms
open-market sale financial
Option to Purchase Common Stock financial
exercise price financial
expiration date financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NHC director HASSAN EMIL E report?
What stock options does the NHC director hold according to this Form 4?
Were any NHC stock options exercised in this insider filing?
Is the NHC director’s sale classified as an open-market transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.